Here, it was tentatively proposed that the side effects of overweight or obesity for the users taking 5HT2AR antagonists might be largely related to this 5HT2AR‐mediated GR regulation. This evidence concerns the gene NR3C1 and obesity due to melanocortin 4 receptor deficiency.